Ilynn Bulatao

856 total citations
18 papers, 582 citations indexed

About

Ilynn Bulatao is a scholar working on Surgery, Hepatology and Transplantation. According to data from OpenAlex, Ilynn Bulatao has authored 18 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Hepatology and 5 papers in Transplantation. Recurrent topics in Ilynn Bulatao's work include Liver Disease and Transplantation (10 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Ilynn Bulatao is often cited by papers focused on Liver Disease and Transplantation (10 papers), Organ Transplantation Techniques and Outcomes (10 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Ilynn Bulatao collaborates with scholars based in United States. Ilynn Bulatao's co-authors include C. Burcin Taner, Darrin L. Willingham, Justin H. Nguyen, David J. Kramer, Dana K. Perry, Lena Sibulesky, Andrew P. Keaveny, Jennifer S. Albrecht, Steven M. Scharf and Sarah E. Tom and has published in prestigious journals such as Blood, SLEEP and Transplantation.

In The Last Decade

Ilynn Bulatao

16 papers receiving 575 citations

Peers

Ilynn Bulatao

SURGE

HEPAT

PHEOH

TRANS

ECP

Gilbert L’Italien United States

Sharon Swain United Kingdom

Samantha Montag United States

Ylana Chalem France

Akhil Shenoy United States

Héctor Pérez‐Grovas Mexico

Jeannette Y. Lee United States

John Spivack United States

Valérie Macioce France

Emilie Trinh Canada

Gilbert L’Italien United States

Ilynn Bulatao

43 ×0.1

SURGE

318 ×0.9

HEPAT

30 ×0.2

PHEOH

35 ×0.3

TRANS

24 ×0.2

ECP

Citations per year, relative to Ilynn Bulatao Ilynn Bulatao (= 1×) peers Gilbert L’Italien

Countries citing papers authored by Ilynn Bulatao

Since Specialization

Citations

This map shows the geographic impact of Ilynn Bulatao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilynn Bulatao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilynn Bulatao more than expected).

Fields of papers citing papers by Ilynn Bulatao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilynn Bulatao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilynn Bulatao. The network helps show where Ilynn Bulatao may publish in the future.

Co-authorship network of co-authors of Ilynn Bulatao

This figure shows the co-authorship network connecting the top 25 collaborators of Ilynn Bulatao. A scholar is included among the top collaborators of Ilynn Bulatao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilynn Bulatao. Ilynn Bulatao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Dilawari, Asma, Marie Krantz, Ilynn Bulatao, et al.. (2025). Cardiac Adverse Events in Patients Receiving Immune Checkpoint Inhibitors in the Adjuvant Setting: An FDA Pooled Analysis. Annals of Noninvasive Electrocardiology. 30(3). e70087–e70087.

Kim, Nina, Ilynn Bulatao, Jonathon Vallejo, et al.. (2024). Response Rate, Event-Free Survival (EFS), and Overall Survival in Higher-Risk Myelodysplastic Syndromes (MDS): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses. Blood. 144(Supplement 1). 1829–1829.

Croteau, David, Ellen Pinnow, Eileen Wu, et al.. (2022). Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration. Drug Safety. 45(2). 169–180. 17 indexed citations

Pinnow, Ellen, et al.. (2021). The Impact of Variability in Patient Exposure During Premarket Clinical Development on Postmarket Safety Outcomes. Clinical Pharmacology & Therapeutics. 110(6). 1512–1525. 5 indexed citations

Bulatao, Ilynn, et al.. (2020). Postmarketing Safety‐Related Regulatory Actions for New Therapeutic Biologics Approved in the United States 2002–2014: Similarities and Differences With New Molecular Entities. Clinical Pharmacology & Therapeutics. 108(6). 1243–1253. 15 indexed citations

Wickwire, Emerson M., et al.. (2019). Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries. SLEEP. 42(4). 105 indexed citations

Harris, Donald G., Ilynn Bulatao, Connor P. Oates, et al.. (2017). Functional status predicts major complications and death after endovascular repair of abdominal aortic aneurysms. Journal of Vascular Surgery. 66(3). 743–750. 35 indexed citations

Harris, Donald G., Connor P. Oates, Ilynn Bulatao, et al.. (2016). PC054. Functional Status Predicts Major Complications and Death After Endovascular Repair of Abdominal Aortic Aneurysms. Journal of Vascular Surgery. 63(6). 169S–170S. 1 indexed citations

Bulatao, Ilynn, et al.. (2015). Radiologic Characterization of Ischemic Cholangiopathy in Donation-After-Cardiac-Death Liver Transplants and Correlation With Clinical Outcomes. American Journal of Roentgenology. 205(5). 976–984. 18 indexed citations

10.

Wadei, Hani M., Ilynn Bulatao, Thomas A. Gonwa, et al.. (2014). Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: Single-center and organ procurement and transplantation network analyses. Liver Transplantation. 20(6). 728–735. 26 indexed citations

11.

Bulatao, Ilynn, Michael G. Heckman, Bhupendra Rawal, et al.. (2014). Avoiding Stay in the Intensive Care Unit After Liver Transplantation: A Score to Assign Location of Care. American Journal of Transplantation. 14(9). 2088–2096. 33 indexed citations

12.

Wadei, Hani M., Andrew P. Keaveny, Barry Rosser, et al.. (2012). Proteinuria Following Sirolimus Conversion is Associated With Deterioration of Kidney Function in Liver Transplant Recipients. Transplantation. 93(10). 1006–1012. 15 indexed citations

13.

Taner, C. Burcin, Ilynn Bulatao, Dana K. Perry, et al.. (2012). Asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors. Transplant International. 25(8). 838–846. 89 indexed citations

14.

Taner, C. Burcin, Ilynn Bulatao, Dana K. Perry, et al.. (2012). Liver transplantation in the critically ill: donation after cardiac death compared to donation after brain death grafts. Annals of Hepatology. 11(5). 679–685. 10 indexed citations

15.

Perry, Dana K., Darrin L. Willingham, Lena Sibulesky, et al.. (2011). Should donation after cardiac death liver grafts be used for retransplantation?. Annals of Hepatology. 10(4). 482–485. 10 indexed citations

16.

Taner, C. Burcin, Ilynn Bulatao, Andrew P. Keaveny, et al.. (2011). Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transplantation. 17(6). 641–649. 31 indexed citations

17.

Taner, C. Burcin, Darrin L. Willingham, Ilynn Bulatao, et al.. (2011). Is a Mandatory Intensive Care Unit Stay Needed After Liver Transplantation? Feasibility of Fast-Tracking to the Surgical Ward After Liver Transplantation. Liver Transplantation. 18(3). 361–369. 58 indexed citations

18.

Taner, C. Burcin, Ilynn Bulatao, Darrin L. Willingham, et al.. (2011). Events in Procurement as Risk Factors for Ischemic Cholangiopathy in Liver Transplantation Using Donation After Cardiac Death Donors. Liver Transplantation. 18(1). 100–111. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact